Leukemogenesis and Ageing
Author Information
Author(s): Mel Greaves
Primary Institution: The Institute of Cancer Research
Hypothesis
What might be the biological basis of the age-associated incidence of B-ALL with p190 BCR-ABL1?
Conclusion
Older cells develop leukemias at a much faster rate than younger cells when transplanted into the same age recipients.
Supporting Evidence
- Older B progenitors have a competitive advantage when expressing BCR-ABL1.
- Age-related fitness decline in stem and progenitor cells might increase selective pressure for oncogenic mutations.
- Older cells transfected with BCR-ABL1 undergo more rapid polyclonal expansion early after transplantation.
Takeaway
As we get older, our cells can become better at turning into leukemia, which is a type of cancer. This might be because older cells have some advantages that help them grow faster.
Methodology
The study involved transplanting 'old' and 'young' cells into recipients and observing the rate of leukemia development.
Limitations
The study does not address all potential biological mechanisms involved in age-associated leukemogenesis.
Want to read the original?
Access the complete publication on the publisher's website